{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:00:39Z","timestamp":1793851239372,"version":"4.6.1"},"reference-count":307,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ophtha.2025.12.028","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:33:05Z","timestamp":1770669185000},"page":"P104-P152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern\u00ae"],"prefix":"10.1016","volume":"133","author":[{"given":"Steven J.","family":"Gedde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Nayak","family":"Kolomeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateki","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen C.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Budenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2025.12.028_bb0005","series-title":"SIGN 50: A guideline developer's handbook","article-title":"Scottish Intercollegiate Guidelines Network. Annex B: Key to evidence statements and grades of recommendations","year":"2008"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0015","unstructured":"GRADE Working Group. Organizations that have endorsed or that are using GRADE. Available at: https:\/\/www.gradeworkinggroup.org\/. Accessed September 6, 2025."},{"key":"10.1016\/j.ophtha.2025.12.028_bb0020","series-title":"Preferred Practice Pattern\u00ae guidelines. Primary open-angle glaucoma","article-title":"American Academy of Ophthalmology Glaucoma Committee","year":"2025"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjo.86.2.238","article-title":"The definition and classification of glaucoma in prevalence surveys","volume":"86","author":"Foster","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0030","first-page":"2224","article-title":"Intraocular pressure in an American community: The Beaver Dam Eye Study","volume":"33","author":"Klein","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0035","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ophtha.2004.01.025","article-title":"Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino Eye Study","volume":"111","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2006.08.031","article-title":"Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension","volume":"114","author":"Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1755-3768.2012.02435.x","article-title":"Comparison of clinicians and an artificial neural network regarding accuracy and certainty in performance of visual field assessment for the diagnosis of glaucoma","volume":"91","author":"Andersson","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.04.022","article-title":"Glaucoma specialist optic disc margin, rim margin, and rim width discordance in glaucoma and glaucoma suspect eyes","volume":"192","author":"Hong","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ICU.0000000000000124","article-title":"Myopia and glaucoma: Sorting out the difference","volume":"26","author":"Hsu","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0060","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ophtha.2005.03.006","article-title":"Determinants and heritability of intraocular pressure and cup- to-disc ratio in a defined older population","volume":"112","author":"Chang","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/726760","article-title":"Risk factors for glaucoma suspicion in healthy young Asian and Caucasian Americans","volume":"2014","author":"Doss","year":"2014","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.exer.2011.05.004","article-title":"Optical coherence tomography (OCT) measurements in Black and White children with large cup-to-disc ratios","volume":"93","author":"El-Dairi","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0075","series-title":"National Academies of Sciences, Engineering, and Medicine. Rethinking race and ethnicity in biomedical research","first-page":"270","year":"2025"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Committee AMA Manual of Style Committee. Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2021.0003","article-title":"Recalibrating the use of race in medical research","volume":"325","author":"Ioannidis","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0090","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine - a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0095","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2015.2262","article-title":"Race, poverty, and medicine in the United States","volume":"313","author":"Bauchner","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0100","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0161-6420(94)31090-6","article-title":"The prevalence of primary open-angle glaucoma in a populationbased study in the Netherlands: The Rotterdam Study","volume":"101","author":"Dielemans","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0105","doi-asserted-by":"crossref","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13; discussion 829-30.","DOI":"10.1001\/archopht.120.6.701"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1994.01090180121046","article-title":"The Barbados Eye Study. Prevalence of open angle glaucoma","volume":"112","author":"Leske","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/archopht.119.12.1819","article-title":"The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER","volume":"119","author":"Quigley","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0161-6420(96)30449-1","article-title":"Prevalence of open-angle glaucoma in Australia: The Blue Mountains Eye Study","volume":"103","author":"Mitchell","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0125","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","article-title":"Prevalence of glaucoma: The Beaver Dam Eye Study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0130","doi-asserted-by":"crossref","unstructured":"Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20; discussion 829-30.","DOI":"10.1001\/archopht.120.6.714"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0135","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among White and Black Americans: The Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0140","first-page":"89","article-title":"The Barbados Eye Studies Group. Incidence of open-angle glaucoma: The Barbados Eye Studies","volume":"119","author":"Leske","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0145","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1167\/iovs.03-0077","article-title":"Risk factors associated with the incidence of open-angle glaucoma: The Visual Impairment Project","volume":"44","author":"Le","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0150","first-page":"335","article-title":"The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975","volume":"24","author":"Leibowitz","year":"1980","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","article-title":"European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study","volume":"114","author":"Miglior","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ophtha.2015.11.004","article-title":"Prevalence, awareness, and risk factors of primary open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011","volume":"123","author":"Kim","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2017.01.008","article-title":"Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese","volume":"176","author":"Pan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0170","first-page":"369","article-title":"Racial variations in the prevalence of primary open-angle glaucoma","volume":"266","author":"Tielsch","year":"1991","journal-title":"The Baltimore Eye Survey. JAMA"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0175","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/archopht.1980.01020041015002","article-title":"Biostatistical analysis of the Collaborative Glaucoma Study: I. Summary report of the risk factors for glaucomatous visual-field defects","volume":"98","author":"Armaly","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0180","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0161-6420(89)32708-4","article-title":"National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies: Part I. Prevalence findings","volume":"96","author":"Mason","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"BESs Study Group. Risk factors for incident open-angle glaucoma: The Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ceo.13008","article-title":"Social, health and ocular factors associated with primary open-angle glaucoma amongst Chinese Singaporeans","volume":"46","author":"Chiam","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cxo.12523","article-title":"The assessment of optical coherence tomographic parameters in subjects with a positive family history of glaucoma","volume":"100","author":"Karti","year":"2017","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0205","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0161-6420(97)30247-4","article-title":"Open-angle glaucoma and diabetes: The Blue Mountains Eye Study","volume":"104","author":"Mitchell","year":"1997","journal-title":"Australia. Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ophtha.2007.04.049","article-title":"Los Angeles Latino Eye Study group. Type 2 diabetes mellitus and the risk of open-angle glaucoma: The Los Angeles Latino Eye Study","volume":"115","author":"Chopra","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1464-5491.2004.01173.x","article-title":"Diabetes mellitus as a risk factor for primary open-angle glaucoma: A meta-analysis","volume":"21","author":"Bonovas","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2014.07.051","article-title":"Diabetes, fasting glucose, and the risk of glaucoma: A meta-analysis","volume":"122","author":"Zhao","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0230","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/bjophthalmol-2017-311359","article-title":"Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: The Singapore Epidemiology of Eye Diseases Study","volume":"102","author":"Tham","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archopht.1995.01100020100038","article-title":"Hypertension, perfusion pressure, and primary open-angle glaucoma: A population-based assessment","volume":"113","author":"Tielsch","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0240","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1995.01100070092031","article-title":"Risk factors for open-angle glaucoma: The Barbados Eye Study","volume":"113","author":"Leske","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0245","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0161-6420(99)90416-5","article-title":"The relationship between glaucoma and myopia: The Blue Mountains Eye Study","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0250","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1034\/j.1600-0420.2001.790603.x","article-title":"Refractive error and glaucoma","volume":"79","author":"Grodum","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ophtha.2006.06.050","article-title":"High myopia and glaucoma susceptibility: The Beijing Eye Study","volume":"114","author":"Xu","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ophtha.2015.07.002","article-title":"The association of refractive error with glaucoma in a multiethnic population","volume":"123","author":"Shen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0265","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(01)00760-6","article-title":"Central corneal thickness in the ocular hypertension treatment study (OHTS)","volume":"108","author":"Brandt","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2017.12.018","article-title":"A prospective longitudinal study to investigate corneal hysteresis as a risk factor for predicting development of glaucoma","volume":"187","author":"Susanna","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/IJG.0000000000001429","article-title":"Risk factors for open-angle glaucoma in persons of Latin American descent","volume":"29","author":"Wurster","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0280","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2019.06.029","article-title":"Associations with corneal hysteresis in a population cohort: Results from 96 010 UK biobank participants","volume":"126","author":"Zhang","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archopht.1977.04450020028004","article-title":"The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma","volume":"95","author":"Drance","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1990.01070060093056","article-title":"Prevalence and significance of optic disc hemorrhage in a longitudinal study of glaucoma","volume":"108","author":"Diehl","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1755-3768.1981.tb08728.x","article-title":"Optic disc haemorrhages precede retinal nerve fibre layer defects in ocular hypertension","volume":"59","author":"Airaksinen","year":"1981","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0300","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0161-6420(96)30572-1","article-title":"Optic disc hemorrhages and progression of glaucoma","volume":"103","author":"Siegner","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0305","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ophtha.2006.06.022","article-title":"Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study","volume":"113","author":"Budenz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2006.08.031","article-title":"Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension","volume":"114","author":"Gordon","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0315","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajo.2016.10.023","article-title":"Thirteen-year follow-up of optic disc hemorrhages in the ocular hypertension treatment study","volume":"174","author":"Budenz","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0320","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0161-6420(96)30511-3","article-title":"Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population","volume":"103","author":"Dielemans","year":"1996","journal-title":"The Rotterdam Study. Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0325","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ophtha.2006.01.066","article-title":"Prospective study of type 2 diabetes mellitus and risk of primary openangle glaucoma in women","volume":"113","author":"Pasquale","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0330","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ophtha.2006.03.063","article-title":"Is diabetes mellitus a risk factor for open-angle glaucoma?: The Rotterdam Study","volume":"113","author":"de Voogd","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0335","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(94)31191-2","article-title":"Open-angle glaucoma and older-onset diabetes: The Beaver Dam Eye Study","volume":"101","author":"Klein","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081775","article-title":"Diabetes mellitus as a risk factor for glaucomatous optic neuropathy","volume":"219","author":"Nakamura","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0345","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1167\/iovs.04-1529","article-title":"Prevalence of open-angle glaucoma in a rural South Indian population","volume":"46","author":"Vijaya","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0350","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1167\/iovs.17-23013","article-title":"Direct and indirect associations between diabetes and intraocular pressure: The Singapore Epidemiology of Eye Diseases Study","volume":"59","author":"Luo","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0355","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/bjo.82.8.862","article-title":"Glaucoma and vasospasm","volume":"82","author":"Broadway","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0360","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(99)00289-5","article-title":"Migraine and tension headache in high-pressure and normal-pressure glaucoma","volume":"129","author":"Cursiefen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-019-0430-2","article-title":"Correlation between structural progression in glaucoma and obstructive sleep apnea","author":"Fan","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0370","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ophtha.2010.01.035","article-title":"Ocular biometry and open-angle glaucoma: The Los Angeles Latino Eye Study","volume":"117","author":"Kuzin","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0375","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0161-6420(97)30075-X","article-title":"Is there an association between migraine headache and open-angle glaucoma?: Findings from the Blue Mountains Eye Study","volume":"104","author":"Wang","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0380","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0161-6420(00)00138-X","article-title":"Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study","volume":"107","author":"Bonomi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0385","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0161-6420(95)31054-8","article-title":"Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: The Rotterdam Study","volume":"102","author":"Dielemans","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0390","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(02)01644-6","article-title":"Anisometropia and degree of optic nerve damage in chronic open-angle glaucoma","volume":"134","author":"Jonas","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0395","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archopht.120.7.954","article-title":"Incident open-angle glaucoma and blood pressure","volume":"120","author":"Leske","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00061198-200408000-00010","article-title":"Open-angle glaucoma and systemic hypertension: The Blue Mountains Eye Study","volume":"13","author":"Mitchell","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0000000000000837","article-title":"Is obstructive sleep apnea associated with progressive glaucomatous optic neuropathy?","volume":"27","author":"Swaminathan","year":"2018","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0410","series-title":"Comprehensive adult medical eye evaluation","article-title":"Preferred Practice Pattern\u00ae guidelines","author":"American Academy of Ophthalmology Preferred Practice Patterns Committee","year":"2025"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0415","unstructured":"Centers for Medicare and Medicaid services. Your medicare coverage: Glaucoma tests. Https:\/\/www.Medicare.Gov\/coverage\/glaucoma-screenings. Accessed September 6, 2025."},{"key":"10.1016\/j.ophtha.2025.12.028_bb0420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.1994.01090130079022","article-title":"Family history and risk of primary open angle glaucoma: The Baltimore Eye Survey","volume":"112","author":"Tielsch","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0425","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.116.12.1640","article-title":"Genetic risk of primary open-angle glaucoma: Population-based familial aggregation study","volume":"116","author":"Wolfs","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0430","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0161-6420(02)01267-8","article-title":"Surgical strategies for coexisting glaucoma and cataract: An evidence-based update","volume":"109","author":"Friedman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0435","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","article-title":"Ocular Hypertension Treatment Study Group. Reduction in intraocular pressure after cataract extraction: The Ocular Hypertension Treatment Study","volume":"119","author":"Mansberger","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.survophthal.2005.02.006","article-title":"Considerations of glaucoma in patients undergoing corneal refractive surgery","volume":"50","author":"Bashford","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0445","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/IJG.0b013e3181639ae2","article-title":"Impact and permanence of LASIK-induced structural changes in the cornea on pneumotonometric measurements: Contributions of flap cutting and stromal ablation","volume":"17","author":"Sanchez-Naves","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/IJG.0b013e31829da1ec","article-title":"Changes in biomechanical properties of the cornea and intraocular pressure after myopic laser in situ keratomileusis using a femtosecond laser for flap creation determined using ocular response analyzer and Goldmann applanation tonometry","volume":"24","author":"Shin","year":"2015","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0455","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archopht.1979.01020010146010","article-title":"Relative afferent pupillary defects in glaucoma without characteristic field loss","volume":"97","author":"Kohn","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0460","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archopht.1987.01060110086038","article-title":"The afferent pupillary defect in asymmetric glaucoma","volume":"105","author":"Brown","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0465","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archopht.119.9.1333","article-title":"Quantification of optic nerve axon loss associated with a relative afferent pupillary defect in the monkey","volume":"119","author":"Kerrison","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/bjo.84.2.186","article-title":"Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of limbal chamber depth in Asians: Modified grading scheme","volume":"84","author":"Foster","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0475","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0002-9394(69)91241-0","article-title":"Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle","volume":"68","author":"Van Herick","year":"1969","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-6257(93)90053-A","article-title":"Sources of error with use of Goldmann-type tonometers","volume":"38","author":"Whitacre","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0485","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10384-006-0343-z","article-title":"Diurnal variation of intraocular pressure in suspected normal-tension glaucoma","volume":"50","author":"Hasegawa","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0490","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ophtha.2007.01.018","article-title":"Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma","volume":"114","author":"Dinn","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0495","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/ICU.0b013e32831eef4f","article-title":"Intraocular pressure measurements throughout the 24 h","volume":"20","author":"Bagga","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0500","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0510","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archopht.126.8.1168","article-title":"Fluctuation of intraocular pressure as a predictor of visual field progression","volume":"126","author":"Nouri-Mahdavi","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0515","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0520","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ophtha.2007.10.031","article-title":"Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study","volume":"115","author":"Caprioli","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0525","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Early Manifest Glaucoma Trial Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0530","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.124.6.793","article-title":"Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma","volume":"124","author":"Barkana","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0535","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/IJG.0b013e318237bfb8","article-title":"The value of intraocular pressure asymmetry in diagnosing glaucoma","volume":"22","author":"Williams","year":"2013","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0540","series-title":"Duane's ophthalmology","year":"2009"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0545","article-title":"Light to dark physiological variation in iridotrabecular angle width","author":"Gazzard","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0550","unstructured":"Spaeth GL, Aruajo S, Azuara A. Comparison of the configuration of the human anterior chamber angle, as determined by the Spaeth gonioscopic grading system and ultrasound biomicroscopy. Trans Am Ophthalmol Soc 1995;93:337-47; discussion 47-51."},{"key":"10.1016\/j.ophtha.2025.12.028_bb0555","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/archopht.119.10.1492","article-title":"Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: Comparison of scanning laser tomography with conventional perimetry and optic disc photography","volume":"119","author":"Chauhan","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0560","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajo.2004.05.072","article-title":"Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss","volume":"138","author":"Mohammadi","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archopht.1991.01080010079037","article-title":"Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.1982.01030030137016","article-title":"Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy","volume":"100","author":"Quigley","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0575","doi-asserted-by":"crossref","unstructured":"Lin SC, Singh K, Jampel HD, et al. Optic nerve head and retinal nerve fiber layer analysis: A report by the American Academy of Ophthalmology. Ophthalmology 2007;114:1937-49.","DOI":"10.1016\/j.ophtha.2007.07.005"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0580","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/IJG.0b013e318093e5bf","article-title":"Preperimetric glaucoma assessment with scanning laser polarimetry (GDx VCC): Analysis of retinal nerve fiber layer by sectors","volume":"16","author":"Baraibar","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0585","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajo.2006.05.004","article-title":"Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects","volume":"142","author":"Lalezary","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0590","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archopht.1994.01090170088028","article-title":"Risk factors for the development of glaucomatous visual field loss in ocular hypertension","volume":"112","author":"Quigley","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0595","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0039-6257(98)00049-6","article-title":"Ophthalmoscopic evaluation of the optic nerve head","volume":"43","author":"Jonas","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0600","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/IJG.0b013e31824c9251","article-title":"Features of optic disc progression in patients with ocular hypertension and early glaucoma","volume":"22","author":"Lloyd","year":"2013","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0605","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IJG.0000000000000015","article-title":"Application of the ISNT rule to neuroretinal rim thickness determined using Cirrus HD optical coherence tomography","volume":"24","author":"Hwang","year":"2015","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0610","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archopht.124.11.1579","article-title":"The ISNT rule and differentiation of normal from glaucomatous eyes","volume":"124","author":"Harizman","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0615","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2017.09.018","article-title":"The ISNT rule: How often does it apply to disc photographs and retinal nerve fiber layer measurements in the normal population?","volume":"184","author":"Poon","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0620","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/08820530009037873","article-title":"The relationship between structural and functional alterations in glaucoma: A review","volume":"15","author":"Johnson","year":"2000","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0625","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archophthalmol.2009.276","article-title":"Prediction of functional loss in glaucoma from progressive optic disc damage","volume":"127","author":"Medeiros","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0630","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.ophtha.2011.06.014","article-title":"The region of largest beta-zone parapapillary atrophy area predicts the location of most rapid visual field progression","volume":"118","author":"Teng","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0635","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1167\/iovs.06-0688","article-title":"The relationship between nerve fiber layer and perimetry measurements","volume":"48","author":"Harwerth","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0640","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.preteyeres.2007.08.001","article-title":"A framework for comparing structural and functional measures of glaucomatous damage","volume":"26","author":"Hood","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0645","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Risk factors for progression of visual field abnormalities in normaltension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0650","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma Trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0655","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2007.04.040","article-title":"Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study","volume":"144","author":"Miglior","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0660","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1167\/iovs.09-3446","article-title":"Spatially consistent, localized visual field loss before and after disc hemorrhage","volume":"50","author":"De Moraes","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0665","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.ophtha.2008.08.024","article-title":"Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes","volume":"115","author":"Jeoung","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0670","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0675","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0680","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ophtha.2006.06.022","article-title":"Ocular Hypertension Treatment Study Group. Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study","volume":"113","author":"Budenz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0685","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/IJG.0000000000000083","article-title":"Changes in retinal nerve fiber layer thickness after optic disc hemorrhage in glaucomatous eyes","volume":"23","author":"Hwang","year":"2014","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0690","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2008.05.031","article-title":"Disc hemorrhages and treatment in the Early Manifest Glaucoma Trial","volume":"115","author":"Bengtsson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0695","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00417-010-1306-0","article-title":"Recurrent disc hemorrhage does not increase the rate of visual field progression","volume":"248","author":"de Beaufort","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0700","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00417-010-1474-y","article-title":"Morphologic and functional glaucomatous change after occurrence of single or recurrent optic disc hemorrhages","volume":"248","author":"Laemmer","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0705","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archophthalmol.2011.72","article-title":"Risk factors for visual field progression in treated glaucoma","volume":"129","author":"De Moraes","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0710","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajo.2007.10.009","article-title":"Glaucoma Modified Rand-Like Methodology Group. A panel assessment of glaucoma management: Modification of existing rand-like methodology for consensus in ophthalmology. Part II: Results and interpretation","volume":"145","author":"Singh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0715","first-page":"254","article-title":"How to use nerve fiber layer examination in the management of glaucoma","volume":"85","author":"Quigley","year":"1987","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0720","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9394(03)00484-7","article-title":"Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy","volume":"136","author":"Medeiros","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0725","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3928\/1081-597X-20020701-11","article-title":"Changes in intraocular pressure after laser in situ keratomileusis for myopia, hyperopia, and astigmatism","volume":"18","author":"Agudelo","year":"2002","journal-title":"J Refract Surg"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0730","doi-asserted-by":"crossref","unstructured":"Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: A report by the American Academy of Ophthalmology. Ophthalmology 2007;114:1779-87.","DOI":"10.1016\/j.ophtha.2007.04.068"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0735","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","article-title":"Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study","volume":"114","author":"Miglior","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0740","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1600-0420.1998.760313.x","article-title":"Applanation tonometry and correction according to corneal thickness","volume":"76","author":"Stodtmeister","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0745","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0161-6420(99)90498-0","article-title":"Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic","volume":"106","author":"Shah","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0750","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0002-9394(03)00424-0","article-title":"Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans","volume":"136","author":"Shimmyo","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0755","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/bulm.1999.0102","article-title":"Determination of the true intraocular pressure and modulus of elasticity of the human cornea in vivo","volume":"61","author":"Orssengo","year":"1999","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0760","series-title":"Intraocular pressure: Reports and consensus statements of the 4th global AIGS consensus meeting on intraocular pressure","year":"2007"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0765","series-title":"World Glaucoma Association consensus series","first-page":"4","article-title":"Intraocular pressure","year":"2007"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0770","doi-asserted-by":"crossref","unstructured":"Kim JW, Chen PP. Central corneal pachymetry and visual field progression in patients with open-angle glaucoma. Ophthalmology 2004;111:2126-32.","DOI":"10.1016\/j.ophtha.2004.04.029"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0775","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bjo.2004.062927","article-title":"Central corneal thickness and progression of the visual field and optic disc in glaucoma","volume":"89","author":"Chauhan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0780","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1167\/iovs.04-0851","article-title":"Central corneal thickness and thickness of the lamina cribrosa in human eyes","volume":"46","author":"Jonas","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0785","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ajo.2005.06.056","article-title":"Central corneal thickness and development of glaucomatous optic disk hemorrhages","volume":"140","author":"Jonas","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0790","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ajo.2005.12.007","article-title":"Central corneal thickness and corneal hysteresis associated with glaucoma damage","volume":"141","author":"Congdon","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0795","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/jop.2006.22.26","article-title":"Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma","volume":"22","author":"Stewart","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0800","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2013.01.032","article-title":"Corneal hysteresis as a risk factor for glaucoma progression: A prospective longitudinal study","volume":"120","author":"Medeiros","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0805","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.ophtha.2010.03.044","article-title":"OHTS CSLO Ancillary Study Group. Predicting the onset of glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study","volume":"117","author":"Weinreb","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0810","doi-asserted-by":"crossref","unstructured":"Chen TC, Hoguet A, Junk AK, et al. Spectral-domain OCT: Helping the clinician diagnose glaucoma: A report by the American Academy of Ophthalmology. Ophthalmology 2018;125:1817-27.","DOI":"10.1016\/j.ophtha.2018.05.008"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2016.10.020","article-title":"Automated segmentation errors when using optical coherence tomography to measure retinal nerve fiber layer thickness in glaucoma","volume":"174","author":"Mansberger","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0820","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.65.5.34","article-title":"Biomechanical correlations between the cornea and the optic nerve head","volume":"65","author":"Pan","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0825","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0161-6420(02)01726-8","article-title":"Automated perimetry: A report by the American Academy of Ophthalmology","volume":"109","author":"Delgado","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0830","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2017.04.021","article-title":"24-2 visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma","volume":"124","author":"De Moraes","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0835","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archopht.118.9.1187","article-title":"Ocular Hypertension Treatment Study Group. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study","volume":"118","author":"Keltner","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0840","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1167\/iovs.11-7795","article-title":"Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0845","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ijg.0000243481.75155.97","article-title":"The results of screening frequency doubling technology perimetry in different locations of the community","volume":"16","author":"Mansberger","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0850","first-page":"413","article-title":"Screening for glaucomatous visual field loss with frequency-doubling perimetry","volume":"38","author":"Johnson","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0855","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(99)00414-6","article-title":"Frequency doubling technology perimetry for detection of glaucomatous visual field loss","volume":"129","author":"Cello","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0860","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ajo.2003.12.009","article-title":"Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss","volume":"137","author":"Medeiros","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0865","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ophtha.2013.09.016","article-title":"Predicting progression of glaucoma from rates of frequency doubling technology perimetry change","volume":"121","author":"Meira-Freitas","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0870","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archopht.121.12.1705","article-title":"Detection of early visual field loss in glaucoma using frequency-doubling perimetry and short-wavelength automated perimetry","volume":"121","author":"Landers","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0875","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9394(00)00946-6","article-title":"Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients","volume":"131","author":"Demirel","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0880","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2020.02.008","article-title":"Pattern electroretinograms in preperimetric and perimetric glaucoma","volume":"215","author":"Jung","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0885","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1167\/iovs.10-6381","article-title":"Pattern electroretinogram in glaucoma suspects: New findings from a longitudinal study","volume":"52","author":"Bode","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201599","article-title":"A comparative study of structural, functional and circulatory parameters in glaucoma diagnostics","volume":"13","author":"Kurysheva","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0895","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/OPTH.S50231","article-title":"Comparison of SWAP and SAP on the point of glaucoma conversion","volume":"7","author":"Havvas","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0900","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ophtha.2009.06.046","article-title":"The ability of short-wavelength automated perimetry to predict conversion to glaucoma","volume":"117","author":"van der Schoot","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0905","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamaophthalmol.2013.5511","article-title":"Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: A prospective study","volume":"132","author":"Liu","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0910","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/OPTH.S511803","article-title":"Virtual reality visual field testing in glaucoma: Benefits and drawbacks","volume":"19","author":"Babel","year":"2025","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0915","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2147\/OPTH.S131160","article-title":"Visual field examination method using virtual reality glasses compared with the Humphrey perimeter","volume":"11","author":"Tsapakis","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0920","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajo.2019.10.005","article-title":"Toward improving the mobility of patients with peripheral visual field defects with novel digital spectacles","volume":"210","author":"Sayed","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0925","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.10.12.10","article-title":"Virtual reality-based and conventional visual field examination comparison in healthy and glaucoma patients","volume":"10","author":"Stapelfeldt","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100035","article-title":"Advanced vision analyzer-virtual reality perimeter: Device validation, functional correlation and comparison with Humphrey field analyzer","volume":"1","author":"Narang","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0935","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.10.3.20","article-title":"A virtual reality-based automated perimeter, device, and pilot study","volume":"10","author":"Montelongo","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0940","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.12.9.19","article-title":"Validation of the Iowa head-mounted open-source perimeter","volume":"12","author":"Heinzman","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0945","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IJG.0000000000002290","article-title":"Reliability of visual field testing in a telehealth setting using a head-mounted device: A pilot study","volume":"33","author":"McLaughlin","year":"2024","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0950","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ogla.2023.08.006","article-title":"Assessment of remote training, at-home testing, and test-retest variability of a novel test for clustered virtual reality perimetry","volume":"7","author":"Chia","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0955","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/ICU.0b013e32834ff431","article-title":"Glaucoma versus red disease: Imaging and glaucoma diagnosis","volume":"23","author":"Chong","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0960","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9394(75)90534-6","article-title":"The use of diagrams to record changes in glaucomatous disks","volume":"80","author":"Shaffer","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0965","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00061198-199612000-00005","article-title":"Interobserver and intraobserver variability in the detection of glaucomatous progression of the optic disc","volume":"5","author":"Coleman","year":"1996","journal-title":"J Glaucoma"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2025.12.028_bb0970","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0039-6257(99)00092-2","article-title":"Topographic analysis to discriminate glaucomatous from normal optic nerve heads with a confocal scanning laser: New optic disk analysis without any observer input","volume":"44","author":"Iester","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0975","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.ijg.0000176938.00768.0d","article-title":"Intraobserver and interobserver reliability indices for drawing scanning laser ophthalmoscope optic disc contour lines with and without the aid of optic disc photographs","volume":"14","author":"Watkins","year":"2005","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0980","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1167\/iovs.07-0111","article-title":"Comparison of HRT-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma","volume":"49","author":"Alencar","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0985","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archopht.122.6.827","article-title":"Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and Stratus OCT optical coherence tomograph for the detection of glaucoma","volume":"122","author":"Medeiros","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0990","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2024.04.022","article-title":"Diagnostic accuracy of optic nerve head and macula OCT parameters for detecting glaucoma in eyes with and without high axial myopia","volume":"266","author":"Rezapour","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb0995","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ICU.0000000000000024","article-title":"Diagnosing glaucoma progression with optical coherence tomography","volume":"25","author":"Leung","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1000","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.survophthal.2013.04.007","article-title":"Imaging of the optic nerve and retinal nerve fiber layer: An essential part of glaucoma diagnosis and monitoring","volume":"59","author":"Kotowski","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2004.11.030","article-title":"European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study","volume":"112","author":"Miglior","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archopht.123.4.464","article-title":"Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma","volume":"123","author":"Wollstein","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1015","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0161-6420(98)91031-4","article-title":"The cupped disc. Who needs neuroimaging?","volume":"105","author":"Greenfield","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archophthalmol.2010.20","article-title":"Delaying treatment of ocular hypertension: The Ocular Hypertension Treatment Study","volume":"128","author":"Kass","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2021.0341","article-title":"Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up","volume":"139","author":"Kass","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archopht.120.6.829","article-title":"Answers from the Ocular Hypertension Treatment Study","volume":"120","author":"Palmberg","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jamaophthalmol.2024.0151","article-title":"Polygenic risk scores for glaucoma onset in the Ocular Hypertension Treatment Study","volume":"142","author":"Singh","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0002-9394(02)01930-X","article-title":"Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics","volume":"135","author":"Johnson","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1045","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ophtha.2004.06.029","article-title":"AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations","volume":"111","author":"Kim","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.121.5.643","article-title":"Classification of visual field abnormalities in the Ocular Hypertension Treatment Study","volume":"121","author":"Keltner","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1055","doi-asserted-by":"crossref","unstructured":"Mansberger SL, Medeiros FA, Gordon M. Diagnostic tools for calculation of glaucoma risk. Surv Ophthalmol 2008;53 Suppl1:S11-6.","DOI":"10.1016\/j.survophthal.2008.08.005"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00061198-200408000-00014","article-title":"A risk calculator to determine the probability of glaucoma","volume":"13","author":"Mansberger","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0b013e31825af795","article-title":"Risk calculation variability over time in ocular hypertensive subjects","volume":"23","author":"Song","year":"2014","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1080","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): A multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LiGHT) trial: Six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1090","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1517\/14656566.8.18.3237","article-title":"Glaucoma: A review of adjunctive therapy and new management strategies","volume":"8","author":"Whitson","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1095","first-page":"S20","article-title":"Current management of glaucoma and the need for complete therapy","volume":"14","author":"McKinnon","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ophtha.2007.10.004","article-title":"Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines","volume":"115","author":"Stewart","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjopharm.2007.05.004","article-title":"Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a medicare managed care population","volume":"5","author":"Bhosle","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9394(88)90828-8","article-title":"Long-term betaxolol therapy in glaucoma patients with pulmonary disease","volume":"106","author":"Weinreb","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archophthalmol.2011.2573","article-title":"Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy","volume":"130","author":"Gulati","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9394(99)00160-9","article-title":"Beta-blocker eyedrops and nocturnal arterial hypotension","volume":"128","author":"Hayreh","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1130","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trials","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1135","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ophtha.2009.01.036","article-title":"Meta-analysis of medical intervention for normal tension glaucoma","volume":"116","author":"Cheng","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bjophthalmol-2014-305908","article-title":"A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: The VOYAGER study","volume":"99","author":"Weinreb","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2016.04.019","article-title":"Efficacy of latanoprostene bunod 0.024% compared with timolol 0.5% in lowering intraocular pressure over 24 hours","volume":"169","author":"Liu","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajo.2016.05.012","article-title":"Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: The LUNAR study","volume":"168","author":"Medeiros","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1155","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2016.01.019","article-title":"Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension: The APOLLO study","volume":"123","author":"Weinreb","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1160","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ophtha.2010.02.020","article-title":"Ocular Hypertension Treatment Study Group. The utility of the monocular trial: Data from the Ocular Hypertension Treatment Study","volume":"117","author":"Bhorade","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1165","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ophtha.2009.01.054","article-title":"A prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma","volume":"116","author":"Realini","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9394(00)00527-4","article-title":"Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study","volume":"130","author":"Piltz","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ophtha.2003.08.022","article-title":"The uniocular drug trial and second-eye response to glaucoma medications","volume":"111","author":"Realini","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","article-title":"Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?","volume":"112","author":"Robin","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: Objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamaophthalmol.2013.7677","article-title":"Effectiveness of intraocular pressure-lowering medication determined by washout","volume":"132","author":"Jampel","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.04.008","article-title":"Intraocular pressure following prerandomization glaucoma medication washout in the HORIZON and COMPASS trials","volume":"216","author":"Johnson","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1200","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0161-6420(99)90461-X","article-title":"Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy","volume":"106","author":"thoe Schwartzenberg GW, Buys YM.","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00061198-200106000-00014","article-title":"Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial","volume":"10","author":"Lee","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00061198-200404000-00008","article-title":"Is addition of a third or fourth antiglaucoma medication effective?","volume":"13","author":"Neelakantan","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1215","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/IJG.0000000000000987","article-title":"The more, the better? The usefulness of brimonidine as the fourth antiglaucoma eye drop","volume":"27","author":"Bro","year":"2018","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archopht.1984.01040030429017","article-title":"Improving the therapeutic index of topically applied ocular drugs","volume":"102","author":"Zimmerman","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1230","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1235","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ajo.2003.10.034","article-title":"Persistency with latanoprost or timolol in primary open-angle glaucoma suspects","volume":"137","author":"Schwartz","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","article-title":"Adherence with topical glaucoma medication monitored electronically: The travatan dosing aid study","volume":"116","author":"Okeke","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1245","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2009.96","article-title":"An objective evaluation of eyedrop instillation in patients with glaucoma","volume":"127","author":"Stone","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1250","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/bjo.2008.139840","article-title":"The influence of disease severity on quality of eye-drop administration in patients with glaucoma or ocular hypertension [letter]","volume":"93","author":"Aptel","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1255","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1260","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ogla.2021.04.006","article-title":"Improved glaucoma medication adherence in a randomized controlled trial","volume":"5","author":"Muir","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1265","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2022.06.025","article-title":"Interventions for glaucoma medication adherence improvement: A network meta-analysis of randomized controlled trials","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1270","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ophtha.2019.09.041","article-title":"Cost-utility analysis of glaucoma medication adherence","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1275","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ogla.2023.01.006","article-title":"Cost-utility analysis of a medication adherence-enhancing educational intervention for glaucoma","volume":"6","author":"Hung","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1280","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajo.2022.08.011","article-title":"Within-trial cost-effectiveness of an adherence-enhancing educational intervention for glaucoma","volume":"244","author":"Williams","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2415-14-79","article-title":"Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: A patient survey","volume":"14","author":"Moore","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1290","year":"2010","journal-title":"Early refill edits on topical ophthalmic products [memorandum]."},{"key":"10.1016\/j.ophtha.2025.12.028_bb1295","article-title":"Analysis of legal verbiage in state legislation for insurer coverage of early eyedrop refills in the United States","author":"Chamberlain","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1300","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/OPTH.S102181","article-title":"Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population","volume":"10","author":"Perera","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1305","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.ophtha.2017.04.022","article-title":"Long-term safety and efficacy of a sustained-release Bimatoprost ocular ring","volume":"124","author":"Brandt","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1310","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: Present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13346-014-0196-9","article-title":"Nanomedicine for glaucoma: Sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops","volume":"4","author":"Wong","year":"2014","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.3.3.8","article-title":"One-year feasibility study of replenish micropump for intravitreal drug delivery: A pilot study","volume":"3","author":"Gutierrez-Hernandez","year":"2014","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40265-019-01248-0","article-title":"24-month phase I\/II clinical trial of Bimatoprost sustained-release implant (Bimatoprost SR) in glaucoma patients","volume":"80","author":"Craven","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40123-019-0161-2","article-title":"Miniaturization in glaucoma monitoring and treatment: A review of new technologies that require a minimal surgical approach","volume":"8","author":"Dick","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1335","article-title":"Durysta (bimatoprost implant) [drug approval] U.S","author":"Allergan, inc.","year":"2020","journal-title":"Food and Drug Administration website. Revised"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1340","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40265-023-01973-7","article-title":"Efficacy and safety of the travoprost intraocular implant in reducing topical IOP-lowering medication burden in patients with open-angle glaucoma or ocular hypertension","volume":"84","author":"Berdahl","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ogla.2019.12.004","article-title":"A practical guide to the pregnant and breastfeeding patient with glaucoma","volume":"3","author":"Belkin","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1350","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archopht.124.8.1089","article-title":"The course of glaucoma during pregnancy: A retrospective case series","volume":"124","author":"Brauner","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1355","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0039-6257(00)00209-5","article-title":"Management of glaucoma in pregnancy and lactation","volume":"45","author":"Johnson","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1360","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.survophthal.2010.11.008","article-title":"Pregnancy and glaucoma","volume":"56","author":"Razeghinejad","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ICU.0000000000000029","article-title":"Glaucoma in pregnancy","volume":"25","author":"Salim","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1370","series-title":"FDA background package for meeting of drug safety and risk management advisory committee (DSARM): Management of drug related teratogenic risk - day one","first-page":"11","author":"U.S. Food and Drug Administration Center for Drug Evaluation and Research","year":"2012"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1375","article-title":"Beta-blockers and their current role in maternal and neonatal health: A narrative review of the literature","volume":"15","author":"Martinez","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1380","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ajo.2004.03.002","article-title":"Latanoprost exposure in pregnancy","volume":"138","author":"De Santis","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/tera.1420370407","article-title":"Acetazolamide: Maternal toxicity, pattern of malformations, and litter effect","volume":"37","author":"Holmes","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1390","series-title":"Rhopressa (netarsudil ophthalmic solution) [package insert]","author":"Aerie pharmaceuticals inc","year":"2017"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1395","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2013-1985","article-title":"The transfer of drugs and therapeutics into human breast milk: An update on selected topics","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1400","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","article-title":"Reduction in intraocular pressure after cataract extraction: The Ocular Hypertension Treatment Study","volume":"119","author":"Mansberger","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1405","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9394(14)70632-4","article-title":"Comparison of methods to evaluate the optic nerve head and nerve fiber layer for glaucomatous change","volume":"121","author":"Caprioli","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1410","first-page":"532","article-title":"Variability of expert observers in evaluating the optic disc","volume":"74","author":"Lichter","year":"1976","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1415","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archopht.1992.01080140062028","article-title":"Rate and pattern of neuroretinal rim area decrease in ocular hypertension and glaucoma","volume":"110","author":"Airaksinen","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1420","first-page":"1419","article-title":"Analysis of progressive change in automated visual fields in glaucoma","volume":"37","author":"Smith","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1425","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0161-6420(95)31060-3","article-title":"Automated perimetry detects visual field loss before manual goldmann perimetry","volume":"102","author":"Katz","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1430","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archopht.1989.01070010205023","article-title":"A clinical study of perimetric probability maps","volume":"107","author":"Heijl","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1435","doi-asserted-by":"crossref","unstructured":"Sit AJ, Chen TC, Takusagawa HL, et al. Corneal hysteresis for the diagnosis of glaucoma and assessment of progression risk: A report by the American Academy of Ophthalmology. Ophthalmology 2023;130:433-42.","DOI":"10.1016\/j.ophtha.2022.11.009"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1440","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2006.05.061","article-title":"Ocular Hypertension Treatment Study Group. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study","volume":"113","author":"Keltner","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: The Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1450","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0161-6420(98)91134-4","article-title":"Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic","volume":"105","author":"Kosoko","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1455","doi-asserted-by":"crossref","unstructured":"Ngan R, Lam DL, Mudumbai RC, Chen PP. Risk factors for noncompliance with follow-up among normaltension glaucoma suspects. Am J Ophthalmol 2007;144:310-1.","DOI":"10.1016\/j.ajo.2007.04.005"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1460","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.126.5.718","article-title":"Functional health literacy in patients with glaucoma in urban settings","volume":"126","author":"Juzych","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1465","first-page":"775","article-title":"Part I. Patient administration of eyedrops: Interview","volume":"14","author":"Kass","year":"1982","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1470","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajo.2006.01.019","article-title":"Ocular hypertension treatment study group (OHTS). Management of ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study","volume":"141","author":"Kymes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1475","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archophthalmol.2010.83","article-title":"Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension","volume":"128","author":"Kymes","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1480","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ophtha.2007.01.040","article-title":"Cost-effectiveness of treating ocular hypertension","volume":"115","author":"Stewart","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1485","doi-asserted-by":"crossref","unstructured":"Burr JM, Mowatt G, Hernandez R, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: A systematic review and economic evaluation. Health Technol Assess 2007;11:III-IV, IX-X, 1-190.","DOI":"10.3310\/hta11410"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1490","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/IJG.0000000000002146","article-title":"It is time to rethink adult glaucoma screening recommendations","volume":"32","author":"Newman-Casey","year":"2023","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1495","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/IJG.0000000000002398","article-title":"Social determinants of health and glaucoma screening and detection in the SIGHT studies","volume":"33","author":"Newman-Casey","year":"2024","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1500","unstructured":"Centers for Medicare and Medicaid Services. Your medicare coverage: Glaucoma tests. Available at: Https:\/\/www.Medicare.Gov\/coverage\/glaucoma-screenings. Accessed September 6, 2025."},{"key":"10.1016\/j.ophtha.2025.12.028_bb1505","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IJG.0000000000001920","article-title":"Lessons learned from 2 large community-based glaucoma screening studies","volume":"30","author":"Kolomeyer","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1510","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.12.10.18","article-title":"Identifying, understanding, and addressing disparities in glaucoma care in the United States","volume":"12","author":"Davuluru","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1515","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ceo.14367","article-title":"Social determinants of health and health disparities in glaucoma: A review","volume":"52","author":"Acuff","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1520","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ophtha.2023.05.021","article-title":"Social deprivation and the risk of screening positive for glaucoma in the mi-SIGHT telemedicine-based glaucoma detection program","volume":"130","author":"Newman-Casey","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1525","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2024.02.022","article-title":"Socioeconomic disparities in glaucoma severity at initial diagnosis: A nationwide electronic health record cohort analysis","volume":"263","author":"Swaminathan","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/IJG.0000000000002513","article-title":"Socioeconomic and racial disparities in primary open angle glaucoma in the United States","volume":"34","author":"Downs","year":"2025","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2025.12.028_bb1535","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/IJG.0000000000002261","article-title":"Racial, ethnic, and socioeconomic disparities in glaucoma onset and severity in a diverse nationwide cohort in the United States","volume":"32","author":"Acuff","year":"2023","journal-title":"J Glaucoma"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025008140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025008140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:29:19Z","timestamp":1776346159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025008140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":307,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0161642025008140"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.12.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern\u00ae","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}